Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Enhancing quality of life among epilepsy surgery patients: Interlinking multiple social and relational determinants.

Shih P, Francis-Auton E, Nikpour A, Herkes G, Bleasel A, Rapport F.

Epilepsy Behav. 2019 Nov 27;102:106721. doi: 10.1016/j.yebeh.2019.106721. [Epub ahead of print]

PMID:
31785483
2.

Guillain-Barré syndrome: clinical features, treatment choices and outcomes in an Australian cohort.

Barnes SL, Herkes GK.

Intern Med J. 2019 Nov 24. doi: 10.1111/imj.14705. [Epub ahead of print]

PMID:
31760675
3.

Impact of chronic health conditions and injury on school performance and health outcomes in New South Wales, Australia: a retrospective record linkage study protocol.

Mitchell R, Cameron CM, Lystad RP, Nielssen O, McMaugh A, Herkes G, Schniering C, Hng TM.

BMJ Paediatr Open. 2019 Sep 3;3(1):e000530. doi: 10.1136/bmjpo-2019-000530. eCollection 2019.

4.

Republished: Successful thrombolysis for acute ischaemic stroke after reversal of dabigatran etexilate with idarucizumab.

Loh CH, Herkes G.

Drug Ther Bull. 2019 Sep;57(9):141-143. doi: 10.1136/dtb.2019.229128rep. Epub 2019 Aug 23.

PMID:
31444223
5.

Heidenhain variant sporadic Creutzfeldt-Jakob disease diagnosed as an autoimmune encephalitis due to a false-positive GAD autoantibody.

Urriola N, Soosapilla K, Herkes G, Nogajski J.

BMJ Case Rep. 2019 May 6;12(5). pii: e229018. doi: 10.1136/bcr-2018-229018.

PMID:
31061195
6.

Successful thrombolysis for acute ischaemic stroke after reversal of dabigatran etexilate with idarucizumab.

Loh CH, Herkes G.

BMJ Case Rep. 2019 May 5;12(5). pii: e229128. doi: 10.1136/bcr-2018-229128.

PMID:
31061182
7.

Promoting faster pathways to surgery: a clinical audit of patients with refractory epilepsy.

Mumford V, Rapport F, Shih P, Mitchell R, Bleasel A, Nikpour A, Herkes G, MacRae A, Bartley M, Vagholkar S, Braithwaite J.

BMC Neurol. 2019 Feb 19;19(1):29. doi: 10.1186/s12883-019-1255-0.

8.

Determinants of health and wellbeing in refractory epilepsy and surgery: The Patient Reported, ImpleMentation sciEnce (PRIME) model.

Rapport F, Shih P, Faris M, Nikpour A, Herkes G, Bleasel A, Kerr M, Clay-Williams R, Mumford V, Braithwaite J.

Epilepsy Behav. 2019 Mar;92:79-89. doi: 10.1016/j.yebeh.2018.11.027. Epub 2019 Jan 8.

9.

Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study.

Langhorne P, O'Donnell MJ, Chin SL, Zhang H, Xavier D, Avezum A, Mathur N, Turner M, MacLeod MJ, Lopez-Jaramillo P, Damasceno A, Hankey GJ, Dans AL, Elsayed A, Mondo C, Wasay M, Czlonkowska A, Weimar C, Yusufali AH, Hussain FA, Lisheng L, Diener HC, Ryglewicz D, Pogosova N, Iqbal R, Diaz R, Yusoff K, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Magazi D, Nilanont Y, Rosengren A, Oveisgharan S, Yusuf S; INTERSTROKE collaborators.

Lancet. 2018 May 19;391(10134):2019-2027. doi: 10.1016/S0140-6736(18)30802-X. Epub 2018 May 17.

PMID:
29864018
10.

Leading up to saying "yes": A qualitative study on the experience of patients with refractory epilepsy regarding presurgical investigation for resective surgery.

Shih P, Nikpour A, Bleasel A, Herkes G, Mitchell R, Seah R, Mumford V, Braithwaite J, Vagholkar S, Rapport F.

Epilepsy Behav. 2018 Jun;83:36-43. doi: 10.1016/j.yebeh.2018.03.028. Epub 2018 Apr 9.

11.

Neutrophil to lymphocyte ratio and early clinical outcomes in patients with acute ischemic stroke.

Yu S, Arima H, Bertmar C, Clarke S, Herkes G, Krause M.

J Neurol Sci. 2018 Apr 15;387:115-118. doi: 10.1016/j.jns.2018.02.002. Epub 2018 Feb 2.

PMID:
29571846
12.

Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence.

Stockings E, Zagic D, Campbell G, Weier M, Hall WD, Nielsen S, Herkes GK, Farrell M, Degenhardt L.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):741-753. doi: 10.1136/jnnp-2017-317168. Epub 2018 Mar 6.

PMID:
29511052
13.

Prescription of antihypertensive medication at discharge influences survival following stroke.

Andrew NE, Kim J, Thrift AG, Kilkenny MF, Lannin NA, Anderson CS, Donnan GA, Hill K, Middleton S, Levi C, Faux S, Grimley R, Gange N, Geraghty R, Ermel S, Cadilhac DA; Australian Stroke Clinical Registry Consortium.

Neurology. 2018 Feb 27;90(9):e745-e753. doi: 10.1212/WNL.0000000000005023. Epub 2018 Jan 31.

PMID:
29386279
14.

Examining health service utilization, hospital treatment cost, and mortality of individuals with epilepsy and status epilepticus in New South Wales, Australia 2012-2016.

Mitchell RJ, Herkes G, Nikpour A, Bleasel A, Shih P, Vagholkar S, Rapport F.

Epilepsy Behav. 2018 Feb;79:9-16. doi: 10.1016/j.yebeh.2017.11.022. Epub 2017 Dec 7.

PMID:
29223007
15.

Better evidence for earlier assessment and surgical intervention for refractory epilepsy (The BEST study): a mixed methods study protocol.

Rapport F, Shih P, Mitchell R, Nikpour A, Bleasel A, Herkes G, Vagholkar S, Mumford V.

BMJ Open. 2017 Aug 21;7(8):e017148. doi: 10.1136/bmjopen-2017-017148.

16.

Immune mediated neuropathy following checkpoint immunotherapy.

Gu Y, Menzies AM, Long GV, Fernando SL, Herkes G.

J Clin Neurosci. 2017 Nov;45:14-17. doi: 10.1016/j.jocn.2017.07.014. Epub 2017 Jul 29. Review.

PMID:
28765062
17.

Risk-adjusted hospital mortality rates for stroke: evidence from the Australian Stroke Clinical Registry (AuSCR).

Cadilhac DA, Kilkenny MF, Levi CR, Lannin NA, Thrift AG, Kim J, Grabsch B, Churilov L, Dewey HM, Hill K, Faux SG, Grimley R, Castley H, Hand PJ, Wong A, Herkes GK, Gill M, Crompton D, Middleton S, Donnan GA, Anderson CS.

Med J Aust. 2017 May 1;206(8):345-350. Erratum in: Med J Aust. 2017 Aug 21;207(4):180.

PMID:
28446116
18.

Reversible cerebral vasoconstriction syndrome.

Perdices M, Herkes G.

Neuropsychol Rehabil. 2018 Mar;28(2):223-233. doi: 10.1080/09602011.2016.1257434. Epub 2016 Dec 5.

PMID:
27915588
19.

Better outcomes for hospitalized patients with TIA when in stroke units: An observational study.

Cadilhac DA, Kim J, Lannin NA, Levi CR, Dewey HM, Hill K, Faux S, Andrew NE, Kilkenny MF, Grimley R, Thrift AG, Grabsch B, Middleton S, Anderson CS, Donnan GA; Australian Stroke Clinical Registry Consortium.

Neurology. 2016 May 31;86(22):2042-8. doi: 10.1212/WNL.0000000000002715. Epub 2016 May 4.

20.

Rationale and design of Short-Term EXenatide therapy in Acute ischaemic Stroke (STEXAS): a randomised, open-label, parallel-group study.

McGrath RT, Hocking SL, Priglinger M, Day S, Herkes GK, Krause M, Fulcher GR.

BMJ Open. 2016 Feb 24;6(2):e008203. doi: 10.1136/bmjopen-2015-008203.

Supplemental Content

Loading ...
Support Center